Clinical Trial: Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763912) titled 'Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.' on Aug. 10.

Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study

Study Start Date: Nov. 24, 2025

Study Type: INTERVENTIONAL

Condition: Bioequivalence

Intervention: DRUG: Reference

Janumet XR, 50 mg/1000 mg, ER tablet, reference

DRUG: Test

Sitagliptin/metformin, ER tablet, 50 mg/1000 mg

Recruitment Status: COMPLETED

Sponsor: ADIUM

Publishe...